FOIA: OHRP Investigation – Brigham and Woment’s Hospital
FOIA: OHRP Investigation – Brigham and Women’s Hospital
Letter page one:
Letter page 2:
Letter page 3:
Similar Posts
Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations
The Alliance for Human Research Protection (AHRP) welcomes the opportunity to respond to the question “What is the Best Way to Protect Children?”
Our recommendation – which is backed up by evidence that children have suffered harm in medical research – is to significantly limit the discretion of IRBs to approve greater than minimal risk research without direct benefit for the child-subjects under 46.406.
We recommend staying the course in requiring that any such proposed experiment undergo a transparent open evaluation with ample opportunity for public oversight and comment – as required under the provisions of 46.407.
FDA’s Lethal Weakness Requires More than Committees
FDA’s Lethal Weakness Requires More than Committees Sun, 7 Nov 2004 Bloomberg News reports that New York State Attorney General Eliot Spitzer requested information from Pfizer about the promotion of some of its drugs for unapproved uses – the recalled diabetes drug, Rezulin and the antidepressant, Zoloft were named. In…
SSRI Defects: Infants Suffer Drug Withdrawal / Adults risk GI bleeding
SSRI Defects: Infants Suffer Drug Withdrawal / Adults risk GI bleeding Wed, 18 May 2005 The Associated Press reports that new research confirms that: “Babies born to women taking antidepressants in the last three months of pregnancy were three times more likely to develop drug-related symptoms than those born to…
Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Proposed Changes to Subpart D Regulations Increase Risks to Children in Non-Therapeutic Research Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations April 18, 2005 The Alliance for Human Research Protection (AHRP) welcomes the opportunity to respond to the question “What…
Examination of Eli Lilly’s Contentions that the BMJ Prozac Documents were Never Missing and Have No Significance
Peter R. Breggin, M.D. 101 East State Street, No. 112 Ithaca, New York 14850 www.breggin.com Phone: 607 272 5328 Fax: 607 272 5329 January 12, 2005 An Examination of Eli Lilly and Company’s Contentions that the BMJ Prozac Documents were Never Missing and Have No Significance A report by Peter…
Despite Vow, Drug Makers Still Wtihhold Data – NYT letters
Despite Vow, Drug Makers Still Wtihhold Data – NYT letters Thu, 9 Jun 2005 An important article by Alex Berenson in The New York Times, “Despite Vow, Drug Makers Still Withhold Data,” corroborated the untrustworthiness of drug manufacturers. Their public pronouncements and promises to fully disclose their clinical trial data-including…